🇺🇸 FDA
Patent

US 12310996

Methods for enhancing immune checkpoint blockade therapy by modulating the microbiome

granted A61KA61K2035/115A61K31/215

Quick answer

US patent 12310996 (Methods for enhancing immune checkpoint blockade therapy by modulating the microbiome) held by The Board of Regents of the University of Texas System expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K2035/115, A61K31/215, A61K35/04, A61K35/17